Effect of Self-Monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial
Tucker KL., Mort S., Yu L-M., Campbell H., Rivero-Arias O., Wilson HM., Allen J., Band R., Chisholm A., Crawford C., Dougall G., Engonidou L., Franssen M., Green M., Greenfield S., Hinton L., Hodgkinson J., Lavallee L., Leeson P., McCourt C., Mackillop L., Sandall J., Santos M., Tarassenko L., Velardo C., Yardley L., Chappell LC., McManus RJ.
ABSTRACT (Abstracted from JAMA 2022;327:1656–1665 It is estimated that approximately 10% of pregnancies worldwide in 2019 were affected by elevated blood pressure (BP). The United Kingdom has previously reported inadequate monitoring of elevated BP as a significant contributing factor to maternal death.